Advertisement

Topics

Mammography Reporting System, Inc. (MRS) Company Profile

09:57 EDT 24th September 2017 | BioPortfolio


News Articles [1314 Associated News Articles listed on BioPortfolio]

GE secures FDA approval for new 2D digital mammography system

GE Healthcare has secured approval from the US Food and Drug Administration (FDA) for its new 2D digital mammography system – Senographe Pristina with Self-Compression.

FDA grants clearance for first 2D digital mammography system with patient-assisted compression

Today, the U.S. Food and Drug Administration cleared the first 2D digital mammography system that allows patients to increase or decrease the amount of compression applied to their own breast before t...

FDA expands labeling for Hologic's 3D mammography system

The FDA has cleared Hologic for expanded labeling of its Genius 3D mammography system for use in routine breast cancer screen -More- 

Mammography Systems Market by Type Analog Mammography Systems, Digital Mammography Systems, and Breast Tomosynthesis Systems, Technology 2D Mammography, 3D Mammography, and Combined 2D and 3D Mammography, and EndUser Inpatient Settings and Ambulatory Surg

Mammography is a technique used for obtaining high resolution images of breast tissues. It helps in the detection of breast cancer and other breastrelated disorders at the initial stages. The techniqu...

Global Select DR Mammography System Market Research Report Forecast 20172022 [Report Updated: 18062017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Select DR Mammography System Market Research Report Forecast 20172022 is a valuable source of insightful data for business ...

Global Select DR Mammography System Market Research Report Forecast 2017 to 2022 [Report Updated: 05072017] Prices from USD $2800

Delivery of the Report will take 23 working days once order is placed.The Global Select DR Mammography System Market Research Report Forecast 20172022 is a valuable source of insightful data for busin...

Mammography Guide Focuses on Shared Decisions

(MedPage Today) -- Begin offering mammography at age 40, says ACOG

Patient-assisted mammography device approved by FDA

Patients will soon have the option to actively assist technologists with their mammography without compromising image quality and minimizing pain, using GE Healthcare’s Senographe Pristina Dueta wi...

Drugs and Medications [30 Associated Drugs and Medications listed on BioPortfolio]

Zolpidem tartrate [NorthStar Rx LLC]

These highlights do not include all the information needed to use zolpidem tartrate safely and effectively. See full prescribing information for zolpidem tartrate tablets.Zolpidem Tartrate Tablets CIV...

Zolpidem tartrate [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use zolpidem tartrate safely and effectively. See full prescribing information for zolpidem tartrate tablets. Zolpidem Tartrate Tablets, U...

Zolpidem tartrate [RedPharm Drug, Inc.]

These highlights do not include all the information needed to use zolpidem tartrate safely and effectively. See full prescribing information for zolpidem tartrate tablets.Zolpidem Tartrate Tablets CIV...

Alprazolam [Sun Pharma Global FZE]

Alprazolam Tablets, USP CIV

Sertraline hydrochloride [NorthStar Rx LLC]

PubMed Articles [2978 Associated PubMed Articles listed on BioPortfolio]

Enhancing Patient Safety Event Reporting. A Systematic Review of System Design Features.

Electronic patient safety event reporting (e-reporting) is an effective mechanism to learn from errors and enhance patient safety. Unfortunately, the value of e-reporting system (a software or web ser...

Announcement: Implementation of the Vaccine Adverse Event Reporting System 2.0 Reporting Form.

The Vaccine Adverse Event Reporting System (VAERS), co-managed by CDC and the Food and Drug Administration (FDA), is the national postmarketing safety monitoring system that accepts reports about adve...

Utility of the Paris System in Reporting Urine Cytology.

To find out the utility of The Paris System (TPS) in reporting urine cytology and to compare it with the reporting system currently used in our laboratory.

Breast cancers detected in only one of two arms of a tomosynthesis (3D-mammography) population screening trial (STORM-2).

The prospective 'screening with tomosynthesis or standard mammography-2 (STORM-2)' trial compared mammography screen-reading strategies and showed that each of integrated 2D/3D-mammography or 2Dsynthe...

Breast cancer detection using single-reading of breast tomosynthesis (3D-mammography) compared to double-reading of 2D-mammography: Evidence from a population-based trial.

Most population breast cancer (BC) screening programs use double-reading of 2D-mammography. We recently reported the screening with tomosynthesis or standard mammography-2 (STORM-2) trial, showing tha...

Clinical Trials [2670 Associated Clinical Trials listed on BioPortfolio]

Computed Tomography Laser Mammography Breast Imaging Device

The purpose of this study is to evaluate the sensitivity and specificity of the CTLM system when used adjunctively with mammography compared to mammography alone in the heterogeneously and...

Computed Radiography (CR) Data Collection for Mammography Computer Aided Detection (CAD)

The objective of this study is to collect an image library of diagnostic digital mammograms using the Carestream CR mammography system from patients who have histological-conformed breast ...

Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System

The purpose of this research study is to investigate the accuracy of a breast imaging system that measures the uptake of the injected radioactive tracer by gamma-ray imaging, known as scin...

Xpress Digital Mammography System Images for Computer Aided Detection Development

The primary objective of this study is to acquire digital mammography images produced by the Xpress Digital Mammography System in order to develop Computer Aided Detection software and sys...

Evaluation of Tomosynthesis for Characterization and the Management of Breast Lesions

Tomosynthesis is an innovative technique developed in digital mammography for obtaining a sectional image of the breast. Mammography has the main disadvantage of being an imaging projectio...

Companies [1135 Associated Companies listed on BioPortfolio]

Mammography Reporting System, Inc. (MRS)

U-Systems

U-Systems is the leader in developing automated breast ultrasound systems and the sponsor of the SOMO•INSIGHT multi-center study that will enroll up to 20,000 women at clinic...

Imaging Diagnostic Systems, Inc.

Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM system is a breast imaging syst...

BioLucent

The company is dedicated to improving the mammography experience with the goal of increasing the number of women who benefit from regular, recommended screening mammograms. Dr. Gail Lebovic, now lead ...

U-Systems, Inc.

U-Systems is the leader in developing dedicated breast ultrasound systems. For more information about the company, please visit our website at http://www.u-systems.com. For...

More Information about "Mammography Reporting System, Inc. (MRS)" on BioPortfolio

We have published hundreds of Mammography Reporting System, Inc. (MRS) news stories on BioPortfolio along with dozens of Mammography Reporting System, Inc. (MRS) Clinical Trials and PubMed Articles about Mammography Reporting System, Inc. (MRS) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mammography Reporting System, Inc. (MRS) Companies in our database. You can also find out about relevant Mammography Reporting System, Inc. (MRS) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record